Download Citation
Article Source:
IGF2 Ameliorates Amyloidosis, Increases Cholinergic Marker Expression and Raises BMP9 and Neurotrophin Levels in the Hippocampus of the APPswePS1dE9 Alzheimer’s Disease Model Mice
Mellott TJ,
Pender SM,
Burke RM,
Langley EA,
Blusztajn JK
(2014)
IGF2 Ameliorates Amyloidosis, Increases Cholinergic Marker Expression and Raises BMP9 and Neurotrophin Levels in the Hippocampus of the APPswePS1dE9 Alzheimer’s Disease Model Mice.
PLOS ONE 9(4): e94287.
https://doi.org/10.1371/journal.pone.0094287